It's a story of mice and men with huge implications: Mayo Clinic researchers and collaborators from the UK have apparently cured mice with well-established prostate tumors with no visible side effects via a new kind of tumor vaccine. And if it works for men like it worked for mice, it could make prostate cancer a preventable condition and open the door to additional cancer vaccines. The findings are preliminary but promising. Geneticists basically assembled a complementary DNA library from healthy prostate tissue and inserted snippets of that genetic code into a swarm of viruses that were introduced to the mice intravenously. This cDNA causes the viruses to produce prostate antigens, basically sending the immune system a distress signal with the prostate's unique signature on it. Related ArticlesElectric Fields Halt Spread of Brain Cancer FDA Approves First Cancer Vaccine, Heralding a New Era in TreatmentCan a Virus Kill Cancer?TagsScience, Clay Dillow, cancer,...
- Mayo Clinic researchers use human vaccine to cure prostate cancer in miceMon, 20 Jun 2011, 0:33:48 EDT
- Vaccine approach extends life of metastatic prostate cancer patientsMon, 25 Jan 2010, 17:24:20 EST
- Reducing intake of dietary fat prevents prostate cancer in miceThu, 15 May 2008, 1:35:58 EDT
- Beehive extract shows potential as prostate cancer treatmentFri, 4 May 2012, 16:34:28 EDT
- Xenotropic murine leukemia virus-related virus may not be associated with human prostate cancerThu, 15 Oct 2009, 20:14:45 EDT